Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Julie Overgaard"'
Autor:
Anne Julie Overgaard, Jens Otto Broby Madsen, Flemming Pociot, Jesper Johannesen, Joachim Størling
Publikováno v:
BMC Pediatrics, Vol 20, Iss 1, Pp 1-6 (2020)
Abstract Background Type 1 diabetes (T1D) is caused by immune-mediated destruction of the β-cells. After initiation of insulin therapy many patients experience a period of improved residual β-cell function leading to partial disease remission. Cyto
Externí odkaz:
https://doaj.org/article/0e89d9b2d8d3473c863595613677f181
Autor:
Sebastian Møller Nguyen Heimbürger, Bjørn Hoe, Chris Neumann Nielsen, Natasha Chidekel Bergman, Kirsa Skov-Jeppesen, Bolette Hartmann, Jens Juul Holst, Flemming Dela, Julie Overgaard, Joachim Størling, Tina Vilsbøll, Thomas Fremming Dejgaard, Jesper Foged Havelund, Vladimir Gorshkov, Frank Kjeldsen, Nils Joakim Færgeman, Martin Rønn Madsen, Mikkel B Christensen, Filip Krag Knop
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 107:3261-3274
Context Glucose-dependent insulinotropic polypeptide (GIP) has been proposed to exert insulin-independent effects on lipid and bone metabolism. Objective We investigated the effects of a 6-day subcutaneous GIP infusion on circulating lipids, white ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48b1e70e9927dfa7789868c4c86ddff5
https://doi.org/10.1210/clinem/dgac542
https://doi.org/10.1210/clinem/dgac542
Autor:
Joachim Størling, Bolette Hartmann, Charles Pyke, Tina Vilsbøll, Mikkel B. Christensen, Filip K. Knop, Anne Julie Overgaard, Chris N. Nielsen, Bjørn Hoe, Flemming Dela, Thomas F. Dejgaard, Sebastian M. Nguyen Heimbürger, Jens J. Holst
Publikováno v:
Diabetes. 70
Glucose-dependent insulinotropic polypeptide (GIP) has been proposed to increase adipose tissue lipolysis (at low insulin levels), adipokine secretion and circulating levels of inflammation markers via the GIP receptor (GIPR) in adipose tissue. We in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f65741ec04b49f69bb0962c7e7f411e0
https://doi.org/10.2337/db21-107-or
https://doi.org/10.2337/db21-107-or
Autor:
Signe Schmidt, Kajetan Trošt, Cristina Legido-Quigley, Tommi Suvitaival, Min Kim, Anne Julie Overgaard, Merete B. Christensen, Kirsten Nørgaard, Flemming Pociot, Ajenthen Ranjan, Naba Al-Sari
Publikováno v:
Endocrinology, Diabetes & Metabolism
Al-Sari, N, Schmidt, S, Suvitaival, T, Kim, M, Trošt, K, Ranjan, A G, Christensen, M B, Overgaard, A J, Pociot, F, Nørgaard, K & Legido-Quigley, C 2021, ' Changes in the lipidome in type 1 diabetes following low carbohydrate diet : Post-hoc analysis of a randomized crossover trial ', Endocrinology, Diabetes and Metabolism, vol. 4, no. 2, e00213 . https://doi.org/10.1002/edm2.213
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 2, Pp n/a-n/a (2021)
Al-Sari, N, Schmidt, S, Suvitaival, T, Kim, M, Trošt, K, Ranjan, A G, Christensen, M B, Overgaard, A J, Pociot, F, Nørgaard, K & Legido-Quigley, C 2021, ' Changes in the lipidome in type 1 diabetes following low carbohydrate diet : Post-hoc analysis of a randomized crossover trial ', Endocrinology, Diabetes and Metabolism, vol. 4, no. 2, e00213 . https://doi.org/10.1002/edm2.213
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 2, Pp n/a-n/a (2021)
Aims Lipid metabolism might be compromised in type 1 diabetes, and the understanding of lipid physiology is critically important. This study aimed to compare the change in plasma lipid concentrations during carbohydrate dietary changes in individuals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ae7f471a65780f029a3fdc9556bdb6d
https://doi.org/10.1002/edm2.213
https://doi.org/10.1002/edm2.213
Publikováno v:
Overgaard, A J, Madsen, J O B, Pociot, F, Johannesen, J & Storling, J 2020, ' Systemic TNF alpha correlates with residual beta-cell function in children and adolescents newly diagnosed with type 1 diabetes ', BMC Pediatrics, vol. 20, no. 1, 446 . https://doi.org/10.1186/s12887-020-02339-8
BMC Pediatrics
BMC Pediatrics, Vol 20, Iss 1, Pp 1-6 (2020)
BMC Pediatrics
BMC Pediatrics, Vol 20, Iss 1, Pp 1-6 (2020)
Background Type 1 diabetes (T1D) is caused by immune-mediated destruction of the β-cells. After initiation of insulin therapy many patients experience a period of improved residual β-cell function leading to partial disease remission. Cytokines are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8533dac19f1fa570a7be6743802ef6f1
https://doi.org/10.1186/s12887-020-02339-8
https://doi.org/10.1186/s12887-020-02339-8
Autor:
Naba Al-Sari, Min Kim, Kirsten Noergaard, Cristina Legido-Quigley, Signe Tandrup Schmidt, Merete B. Christensen, Ajenthen Ranjan, Kajetan Trošt, Anne Julie Overgaard, Tommi Suvitaival, Flemming Pociot
Aims/hypothesisLipid metabolism might be compromised in type 1 diabetes and the understanding of their physiology is critically important. This study aimed to compare the change in plasma lipid concentrations during carbohydrate dietary changes in in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e42f07f0434d4f8fb5485503e918b7c4
https://doi.org/10.1101/2020.09.17.20196394
https://doi.org/10.1101/2020.09.17.20196394
Autor:
Anne Julie Overgaard, Reza Yarani, Simranjeet Kaur, Aashiq H. Mirza, Flemming Pociot, Verena Hirschberg Jensen, Joana Melo, Joachim Størling, Caroline Frørup
Publikováno v:
RNA Technologies ISBN: 9783030447427
Diabetes is characterized by an insufficient physiological response to increases in blood glucose. There are two major types of diabetes: type 1 diabetes (T1D) and type 2 diabetes (T2D). T1D is the result of an immune-mediated destruction of the panc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75cd03049bf97c2c8377c82a1d9ca607
https://doi.org/10.1007/978-3-030-44743-4_20
https://doi.org/10.1007/978-3-030-44743-4_20
Autor:
Simranjeet Kaur, Anne Julie Overgaard, Marlena Maziarz, Agnes Andersson Svärd, Tommi Suvitaival, Åke Lernmark, Kajetan Trošt, Flemming Pociot
Publikováno v:
Metabolomics
Andersson Svärd, A, Kaur, S, Trôst, K, Suvitaival, T, Lernmark, Å, Maziarz, M, Pociot, F, Overgaard, A J & DiPiS Study Group 2020, ' Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort ', Metabolomics : Official journal of the Metabolomic Society, vol. 16, no. 10, 10 . https://doi.org/10.1007/s11306-020-01730-x
Andersson Svärd, A, Kaur, S, Trôst, K, Suvitaival, T, Lernmark, Å, Maziarz, M, Pociot, F, Overgaard, A J & DiPiS Study Group 2020, ' Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort ', Metabolomics : Official journal of the Metabolomic Society, vol. 16, no. 10, 10 . https://doi.org/10.1007/s11306-020-01730-x
Introduction Type 1 diabetes (T1D) is caused by the destruction of pancreatic islet beta cells resulting in total loss of insulin production. Recent studies have suggested that the destruction may be interrelated to plasma lipids. Objectives Specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff36ad134a78aae309b4ce48456674c2
https://pubmed.ncbi.nlm.nih.gov/33033923
https://pubmed.ncbi.nlm.nih.gov/33033923
Autor:
Anne Julie Overgaard, Steffen U. Thorsen, Louise D. Jacobsen, Thomas H. Hansen, Henrik B. Mortensen, Julie Nyholm Kyvsgaard, Flemming Pociot, Jannet Svensson, Søren Husted, Christian Bressen Pipper
Publikováno v:
Pediatric Diabetes. 18:637-642
Aim Immunologic events during fetal life may play a part in the pathogenesis of type 1 diabetes (T1D). As zinc is involved in immunologic processes, the purpose was to investigate perinatal zinc status and the later risk of developing T1D and associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66967af021b2977dcc75c0cb9db57467
https://doi.org/10.1111/pedi.12476
https://doi.org/10.1111/pedi.12476
Autor:
Lene Dreyer, Henrik Gudbergsen, Sabrina Mai Nielsen, F. Krag Knop, Marius Henriksen, Kristian Zobbe, Anne Julie Overgaard, Henning Bliddal, Lisa K. Stamp, Robin Christensen, Lars E. Kristensen
Publikováno v:
Annals of the Rheumatic Diseases. 79:107.1-108
Background:There is a strong association between gout and obesity. Lowering urate is the cornerstone of gout management [1] and urate levels correlate strongly with central obesity. Previous studies suggest that weight loss has a positive effect on s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6d47b9ba0c45c082887e62353bdcc7f
https://doi.org/10.1136/annrheumdis-2020-eular.3088
https://doi.org/10.1136/annrheumdis-2020-eular.3088